Pregnancy Complicated by Gorham–Stout Disease and Refractory Chylothorax

Abstract

Introduction Gorham–Stout Disease (GSD) is a rare disorder of bony destruction due to lymphangiomatosis, and is often triggered by hormones. One complication of GSD is the development of chylothorax, which carries a high mortality rate. Very little experience has been published to guide management in GSD during pregnancy to optimize both fetal and maternal health.

Case Study A 20-year-old woman with known GSD presented with shortness of breath at 18 weeks of pregnancy, due to bilateral chylothoraces which required daily drainage. To minimize chylous fluid formation, she was placed on bowel rest with total parenteral nutrition (limiting lipid intake) and received octreotide to decrease splanchnic blood flow and chylous fluid drainage. Treatment options were limited due to her pregnancy. Twice daily home chest tube drainage of a single lung cavity, total parenteral nutrition, octreotide, and albumin infusions allowed successful delivery of a healthy 37 weeks' gestation infant by cesarean delivery.

Discussion This case illustrates the management of a rare clinical disease of bone resorption and lymphangiomatosis complicated by bilateral, refractory chylothoraces, triggered by pregnancy, in whom treatment options are limited, and the need for a multidisciplinary health care team to ensure successful maternal and fetal outcomes.

Keywords

pregnancy - chylothorax - Gorham–Stout disease - total parenteral nutrition - octreotide

• References

• 1 Jackson JB. A boneless arm. Boston Med Surg J 1838; 18: 368-369
• 2 Dellinger MT, Garg N, Olsen BR. Viewpoints on vessels and vanishing bones in Gorham-Stout disease. Bone 2014; 63: 47-52
• 3 Tie ML, Poland GA, Rosenow III EC. Chylothorax in Gorham's syndrome. A common complication of a rare disease. Chest 1994; 105 (1) 208-213
• 4 Hagendoorn J, Yock TI, Borel Rinkes IH, Padera TP, Ebb DH. Novel molecular pathways in Gorham disease: implications for treatment. Pediatr Blood Cancer 2014; 61 (3) 401-406
• 5 Möller G, Priemel M, Amling M, Werner M, Kuhlmey AS, Delling G. The Gorham-Stout syndrome (Gorham's massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br 1999; 81 (3) 501-506
• 6 Kiran DN, Anupama A. Vanishing bone disease: a review. J Oral Maxillofac Surg 2011; 69 (1) 199-203
• 7 Hu P, Yuan XG, Hu XY, Shen FR, Wang JA. Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B 2013; 14 (8) 729-735
• 8 Liu Y, Zhong DR, Zhou PR , et al. Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature. Clin Rheumatol 2016; 35 (3) 813-823
• 9 Kose M, Pekcan S, Dogru D , et al. Gorham-Stout Syndrome with chylothorax: successful remission by interferon alpha-2b. Pediatr Pulmonol 2009; 44 (6) 613-615
• 10 Riantawan P, Tansupasawasdikul S, Subhannachart P. Bilateral chylothorax complicating massive osteolysis (Gorham's syndrome). Thorax 1996; 51 (12) 1277-1278
• 11 Brunelli A, Catalini G, Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int J Gynaecol Obstet 1996; 52 (3) 289-290
• 12 Patel DV. Gorham's disease or massive osteolysis. Clin Med Res 2005; 3 (2) 65-74
• 13 Nikolaou VS, Chytas D, Korres D, Efstathopoulos N. Vanishing bone disease (Gorham-Stout syndrome): A review of a rare entity. World J Orthod 2014; 5 (5) 694-698
• 14 Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 1955; 37-A (5) 985-1004
• 15 Lala S, Mulliken JB, Alomari AI, Fishman SJ, Kozakewich HP, Chaudry G. Gorham-Stout disease and generalized lymphatic anomaly—clinical, radiologic, and histologic differentiation. Skeletal Radiol 2013; 42 (7) 917-924
• 16 Heyden G, Kindblom LG, Nielsen JM. Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am 1977; 59 (1) 57-61
• 17 Dickson GR, Hamilton A, Hayes D, Carr KE, Davis R, Mollan RA. An investigation of vanishing bone disease. Bone 1990; 11 (3) 205-210
• 18 Hirayama T, Sabokbar A, Itonaga I, Watt-Smith S, Athanasou NA. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 2001; 195 (5) 624-630
• 19 Choma ND, Biscotti CV, Bauer TW, Mehta AC, Licata AA. Gorham's syndrome: a case report and review of the literature. Am J Med 1987; 83 (6) 1151-1156
• 20 Heyd R, Micke O, Surholt C , et al; German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). Radiation therapy for Gorham-Stout syndrome: results of a national patterns-of-care study and literature review. Int J Radiat Oncol Biol Phys 2011; 81 (3) e179-e185
• 21 Dunbar SF, Rosenberg A, Mankin H, Rosenthal D, Suit HD. Gorham's massive osteolysis: the role of radiation therapy and a review of the literature. Int J Radiat Oncol Biol Phys 1993; 26 (3) 491-497
• 22 Grunewald TG, Damke L, Maschan M , et al. First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 2010; 21 (8) 1733-1734
• 23 Nir V, Guralnik L, Livnat G , et al. Propranolol as a treatment option in Gorham-Stout syndrome: a case report. Pediatr Pulmonol 2014; 49 (4) 417-419
• 24 Brodszki N, Länsberg JK, Dictor M , et al. A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax. Acta Paediatr 2011; 100 (11) 1448-1453
• 25 Guba M, von Breitenbuch P, Steinbauer M , et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8 (2) 128-135
• 26 Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg 2016; 49 (1) 18-24